Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126,273,814
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
4,977,699
-
Shares change
-
+594,793
-
Total reported value, excl. options
-
$19,103,728
-
Value change
-
+$2,285,403
-
Number of buys
-
20
-
Number of sells
-
24
-
Price
-
$3.84
Institutional Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q3 2020
As of 30 Sep 2020 Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) had 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,977,699 shares of stock of the company.
Largest 10 holders included BlackRock Inc., GRANAHAN INVESTMENT MANAGEMENT INC/MA, Prosight Management, LP, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, NORTHERN TRUST CORP, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and BANK OF MONTREAL /CAN/.
This table shows 54 institutional shareholders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.